The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients

Transplantation

Volumn 61, Issue 8, 1996, Pages 1206-1210

  Kneteman, Norman M ^a,b   Lakey, Jonathan R T ^a   Wagner, Tracy ^a   Finegood, Diane ^a,b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Alberta Heritage Medical Research Fund   (Canada)

^c Medical Research Council of   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INSULIN; RAPAMYCIN;

ANIMAL EXPERIMENT; ARTICLE; DOG; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN SENSITIVITY; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; CYCLOSPORINE; DOGS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; POLYENES; SIROLIMUS;

EID: 0029975996     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604270-00015     Document Type: Article

References (21)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993; 329: 977.
2. Hering BJ, Browatzki CC, Schultz A, et al. Clinical islet transplantation - registry report, accomplishments in the past and future research needs. Cell Transplantation 1993; 2: 269.
3. Hering BJ. International Islet Transplant Registry. 1995; 5: 24.
4. Rooth PE, Dawidson K, Laferty K, et al. Prevention of detrimental effect of cyclosporine A on vascular ingrowth of transplanted pancreatic islets with Verapamil. Diabetes 1989; 38(suppl 1): 202.
5. Stöckmann F, Fehmann H-C, Göke B, et al. Impairment of stimulated insulin release from the isolated perfused rat pancreas by cyclosporine pretreatment. Transplantation 1989; 48: 381.
6. Whalstrom HE, Lavelle-Jones M, Endres D, et al. Inhibition of insulin release by cyclosporine and production of peripheral insulin resistance in the dog. Transplantation 1990; 49: 600.
7. Alejandro R, Feldman EC, Bloom AD, Kenyon NS. Effects of cyclosporine on insulin and C-peptide secretion in healthy beagles. Diabetes 1989; 38: 698.
8. Yale J-F, Chamelain M, Courchesne S, Vigeant C. Peripheral insulin resistance and decreased insulin secretion after cyclosporine A treatment. Transplant Proc 1988; 20: 985.
9. Baumgartner D, Schlumpf R, Largiader F. Cyclosporine A interferes with postoperative blood glucose control after clinical pancreas transplantation. Transplant Proc 1987; 19: 4009.
10. Yakimets WJ, Lakey JRT, Yatscoff W, et al. Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses. Transplantation 1993; 56: 1293.
11. Yatscoff RW, Faraci C, Bolingbroke P. Measurement of rapamycin in whole blood using reverse-phase high-performance liquid chromatography. Ther Drug Monit 1992; 14: 138.
12. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system-plasma insulin lends of normal subdiabetic and diabetic rats. Diabetes 1963; 12: 115.
13. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comp Meth Prog Biomed 1986; 23: 113.
14. Tobin BW, Lewis JT, Tobin BL, Rajotte RV, Finegood DT. Markedly reduced β-cell function does not result in insulin resistance in islet autografted dogs. Diabetes 1992; 41: 1172.
15. Kahn SE, Bergman RN, Schwartz MW, Taborsky GJ Jr, Porte D Jr. Short-term hyperglycemia and hyperinsulinemia improve insulin action but do not alter glucose action in normal humans. Am J Physiol 1992; 262: E518.
16. Moorhouse JA, Grahman GR, Rosen NJ. Relationship between intravenous glucose tolerance and the fasting plasma glucose level in healthy and diabetic subjects. J Clin Endocrinol 1964; 24: 145.
17. Kneteman NM, Marchetti P, Tordjman K, et al. Effects of cyclosporine on insulin secretion and insulin sensitivity in dogs with islet autotransplant. Surgery 1992; 111: 430.
18. Fabian MC, Lakey JRT, Rajotte RV, Kneteman NM. The efficacy and toxicity of rapamycin in murine islet transplantation: in vitro and in vivo studies. Transplantation 1993; 56: 1137.
19. Collier DS, Calne RY, Pollard SG, et al. Rapamycin in experimental renal allografts in primates. Transplant Proc 1991; 23: 2246.
20. Stepkowski SM, Chen H, Daloze P, Kahan BD. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 1991; 51: 22.
21. Kuo CJ, Chung J, Fiorentino DF, et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 1992; 358: 70.